BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23084894)

  • 1. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain.
    Brumfield S; Korakas P; Silverman LS; Tulshian D; Matasi JJ; Qiang L; Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Wu WL; Sasikumar TK; Domalski M; Bertorelli R; Grilli M; Lozza G; Reggiani A; Li C
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7223-6. PubMed ID: 23084894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
    Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.
    Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Heimark L; Pramanik B; Grilli M; Bertorelli R; Lozza G; Reggiani A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3199-203. PubMed ID: 19433355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of novel orally active mGluR5 antagonist GSK2210875.
    Pilla M; Andreoli M; Tessari M; Delle-Fratte S; Roth A; Butler S; Brown F; Shah P; Bettini E; Cavallini P; Benedetti R; Minick D; Smith P; Tehan B; D'Alessandro P; Lorthioir O; Ball C; Garzya V; Goodacre C; Watson S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7521-4. PubMed ID: 21051228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.
    El-Kouhen O; Lehto SG; Pan JB; Chang R; Baker SJ; Zhong C; Hollingsworth PR; Mikusa JP; Cronin EA; Chu KL; McGaraughty SP; Uchic ME; Miller LN; Rodell NM; Patel M; Bhatia P; Mezler M; Kolasa T; Zheng GZ; Fox GB; Stewart AO; Decker MW; Moreland RB; Brioni JD; Honore P
    Br J Pharmacol; 2006 Nov; 149(6):761-74. PubMed ID: 17016515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of selective mGluR1 antagonists].
    Yang YL; Sun W; Peng C; Zhang XY; Yang XH
    Yao Xue Xue Bao; 2011 Oct; 46(10):1167-72. PubMed ID: 22242445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
    Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists.
    Zheng GZ; Bhatia P; Kolasa T; Patel M; El Kouhen OF; Chang R; Uchic ME; Miller L; Baker S; Lehto SG; Honore P; Wetter JM; Marsh KC; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4936-40. PubMed ID: 16809035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
    Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
    Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
    Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic activity of metabotropic glutamate receptor 1 antagonists on spontaneous post-operative pain in rats.
    Zhu CZ; Baker S; EI-Kouhen O; Lehto SG; Hollingsworth PR; Gauvin DM; Hernandez G; Zheng G; Chang R; Moreland RB; Stewart AO; Brioni JD; Honore P
    Eur J Pharmacol; 2008 Feb; 580(3):314-21. PubMed ID: 18054908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel thienopyrimidinones as mGluR1 antagonists.
    Kim Y; Kim J; Kim S; Ki Y; Seo SH; Tae J; Ko MK; Jang HS; Lim EJ; Song C; Cho Y; Koh HY; Chong Y; Choo IH; Keum G; Min SJ; Choo H
    Eur J Med Chem; 2014 Oct; 85():629-37. PubMed ID: 25127154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of P2X3 selective antagonists for the treatment of chronic pain.
    Cantin LD; Bayrakdarian M; Buon C; Grazzini E; Hu YJ; Labrecque J; Leung C; Luo X; Martino G; Paré M; Payza K; Popovic N; Projean D; Santhakumar V; Walpole C; Yu XH; Tomaszewski MJ
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2565-71. PubMed ID: 22370269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.
    Nataraja Sekhar Y; Ravikumar M; Ravi Shashi Nayana M; Mallena SC; Kishore Kumar M
    Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and biological evaluation of tetrahydrothieno[2,3-c]pyridine derivatives as selective metabotropic glutamate receptor 1 antagonists for the potential treatment of neuropathic pain.
    Nam M; Kim T; Kwak J; Seo SH; Ko MK; Lim EJ; Min SJ; Cho YS; Keum G; Baek DJ; Lee J; Pae AN
    Eur J Med Chem; 2015 Jun; 97():245-58. PubMed ID: 25984841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: a potential treatment for psychotic disorders.
    Ito S; Hirata Y; Nagatomi Y; Satoh A; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Ohta H; Kawamoto H
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5310-3. PubMed ID: 19692242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid hit to lead evaluation of pyrazolo[3,4-d]pyrimidin-4-one as selective and orally bioavailable mGluR1 antagonists.
    Wang X; Kolasa T; El Kouhen OF; Chovan LE; Black-Shaefer CL; Wagenaar FL; Garton JA; Moreland RB; Honore P; Lau YY; Dandliker PJ; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4303-7. PubMed ID: 17532216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
    Wu WL; Burnett DA; Domalski M; Greenlee WJ; Li C; Bertorelli R; Fredduzzi S; Lozza G; Veltri A; Reggiani A
    J Med Chem; 2007 Nov; 50(23):5550-3. PubMed ID: 17929793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
    Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain.
    Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Korakas P; Li C; Tulshian D; Wu WL; Bertorelli R; Fredduzzi S; Grilli M; Lozza G; Reggiani A; Veltri A
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1575-8. PubMed ID: 22266036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.